EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 34 (October 2018) Focus issue F1 Med Sci (Paris), 34 (2018) 26-32 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 26 - 32
DOI https://doi.org/10.1051/medsci/201834f105
Publié en ligne 7 novembre 2018
  1. Charles MP, Kali A, Easow JM, Joseph NM, Ravishankar M, Srinivasan S, et al. Ventilator-associated pneumonia. Australasian Med J 2014 ; 7 : 334–344. [CrossRef] [Google Scholar]
  2. Guillamet CV, Kollef MH. Update on ventilator-associated pneumonia. Curr Opin Crit Care 2015 ; 21 : 430–438. [CrossRef] [PubMed] [Google Scholar]
  3. Bekaert M, Timsit JF, Vansteelandt S, Depuydt P, Vesin A, Garrouste-OrgeasM, et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med 2011 ; 184 : 1133–1139. [CrossRef] [PubMed] [Google Scholar]
  4. de Pont AC. Attributable mortality of ventilator-associated pneumonia. Lancet Infect Dis 2013 ; 13 : 1014. [CrossRef] [PubMed] [Google Scholar]
  5. Timsit JF, Zahar JR, Chevret S. Attributable mortality of ventilator-associated pneumonia. Curr Opin Crit Care 2011 ; 17 : 464–471. [CrossRef] [PubMed] [Google Scholar]
  6. Eagye KJ, Nicolau DP, Kuti JL. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia. Semin Resp Crit Care Med 2009 ; 30 : 116–123. [CrossRef] [Google Scholar]
  7. Kappstein I, Schulgen G, Beyer U, Geiger K, Schumacher M, Daschner FD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992 ; 11 : 504–508. [CrossRef] [PubMed] [Google Scholar]
  8. Nicasio AM, Eagye KJ, Kuti EL, Nicolau DP, Kuti JL. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia. Pharmacotherapy 2010 ; 30 : 453–462. [CrossRef] [PubMed] [Google Scholar]
  9. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999 ; 81 : 417–421. [CrossRef] [PubMed] [Google Scholar]
  10. Dominguez-Comesana E, Estevez-Fernandez SM, Lopez-Gomez V, Ballinas-Miranda J, Dominguez-Fernandez R. Procalcitonin and C-reactive protein as early markers of postoperative intra-abdominal infection in patients operated on colorectal cancer. Int J Colorect Dis 2017. [Google Scholar]
  11. Tachyla SA, Marochkov AV, Lipnitski AL, Nikiforova YG. The prognostic value of procalcitonin, C-reactive protein and cholesterol in patients with an infection and multiple organ dysfunction. Korean J Anesthesiol 2017 ; 70 : 305–310. [CrossRef] [PubMed] [Google Scholar]
  12. Habib SF, Mukhtar AM, Abdelreheem HM, Khorshied MM, El Sayed R, Hafez MH, et al. Diagnostic values of CD64, C-reactive protein and procalcitonin in ventilator-associated pneumonia in adult trauma patients: a pilot study. Clin Chem Lab Med 2016 ; 54 : 889–895. [CrossRef] [PubMed] [Google Scholar]
  13. Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 2008 ; 45 : 293–298. [CrossRef] [Google Scholar]
  14. Zilberberg MD, Shorr AF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis 2010 ; 51 : suppl 1 S131–S135. [CrossRef] [PubMed] [Google Scholar]
  15. Allaouchiche B, Jaumain H, Dumontet C, Motin J. Early diagnosis of ventilator-associated pneumonia. Is it possible to define a cutoff value of infected cells in BAL fluid?. Chest 1996 ; 110 : 1558–1565. [CrossRef] [PubMed] [Google Scholar]
  16. Mongodi S, Via G, Girard M, Rouquette I, Misset B, Braschi A, et al. Lung Ultrasound for Early Diagnosis of Ventilator-Associated Pneumonia. Chest 2016 ; 149 : 969–980. [CrossRef] [PubMed] [Google Scholar]
  17. Lauzier F, Ruest A, Cook D, Dodek P, Albert M, Shorr AF, et al. The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia. J Crit Care 2008 ; 23 : 50–57. [CrossRef] [PubMed] [Google Scholar]
  18. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic „blind“ bronchoalveolar lavage fluid. Am Rev Respir Dis 1991 ; 143 : 1121–1129. [CrossRef] [PubMed] [Google Scholar]
  19. Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995 ; 152 : 1982–1991. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.